Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is $133.31, with a 24-hour trading volume of $296.08M. The asset's market cap is $329.41B, after moving 1.95% in the last day.
Tokenized Merck & Co Inc is trading at $135.19, with a tokenized market cap of $42.93M and a 24-hour trading volume of $706.95K. The tokenized asset has moved 0.33% in the past 24 hours.